Lumira Cancer Breakthrough Fund

PRODUCT ISSUER

Lumira Ventures, an established fund manager. Based in Ontario, investing across North America. The Terry Fox Foundation, a cancer research charity, has partnered with Lumina Ventures to develop this fund, leveraging Lumira Venture’s investment expertise to support its mission. 

PRODUCT

Many cancers lack effective therapies. At the same time, many cancer-fighting biomedical breakthroughs lack the funding and expertise to commercialize. Tapping into the Terry Fox Foundation’s nationwide network of researchers and clinicians, Lumira Cancer Breakthrough Fund is investing in novel cancer therapies and technologies and providing deep operational, clinical and commercialization support in order to accelerate the development of transformative cancer solutions, close critical gaps in treatment and improve patient outcomes.

Main Impact Area: Quality Health Care

Asset Class: Venture Capital